Variant report
Variant | nsv527755 |
---|---|
Chromosome Location | chr2:78900269-78920161 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-REG3G-6 | chr2:78913797-78913805 | NONHSAT071853 |
2 | lnc-REG3G-6 | chr2:78918402-78918413 | NONHSAT071853 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6716040 | chr2:78900269-78900270 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs371868356 | chr2:78900288-78900289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376208057 | chr2:78900345-78900346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551746803 | chr2:78900355-78900356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148992633 | chr2:78900357-78900358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143763879 | chr2:78900376-78900377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs57428381 | chr2:78900377-78900378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180995815 | chr2:78900391-78900392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs187469911 | chr2:78901852-78901853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568841271 | chr2:78901881-78901882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560776980 | chr2:78901915-78901916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191471936 | chr2:78902028-78902029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550986237 | chr2:78902045-78902046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570877910 | chr2:78902112-78902113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs118051002 | chr2:78902119-78902120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538390974 | chr2:78902140-78902141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553605718 | chr2:78902157-78902158 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182843441 | chr2:78902186-78902187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs207461921 | chr2:78902221-78902222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536049149 | chr2:78902224-78902225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs556654137 | chr2:78902236-78902237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188169670 | chr2:78902245-78902246 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs59174671 | chr2:78902252-78902253 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs192228257 | chr2:78902255-78902256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572423599 | chr2:78902291-78902292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541792764 | chr2:78902294-78902295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561411658 | chr2:78902401-78902402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs575009232 | chr2:78902437-78902438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543630903 | chr2:78902439-78902440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563879851 | chr2:78902443-78902444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531322510 | chr2:78902494-78902495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs551024875 | chr2:78902499-78902500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546729545 | chr2:78902511-78902512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527288522 | chr2:78902532-78902533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1272308 | chr2:78902571-78902572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184296879 | chr2:78902575-78902576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567433912 | chr2:78902587-78902588 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs536476055 | chr2:78902635-78902636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115212044 | chr2:78902672-78902673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs138086167 | chr2:78902727-78902728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs539137754 | chr2:78902779-78902780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs149524219 | chr2:78902881-78902882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144048695 | chr2:78902963-78902964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565046921 | chr2:78903021-78903022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376697377 | chr2:78903083-78903084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375495364 | chr2:78903142-78903143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532452734 | chr2:78903165-78903166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs187935227 | chr2:78903195-78903196 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192308485 | chr2:78903217-78903218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs368770282 | chr2:78903218-78903219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Lung cancer | 18438408 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Mental retardation | 17124404 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Cancer | 17440070 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Breast cancer | 16272173 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:78900200-78900400 | Enhancers | Fetal Muscle Trunk | muscle |
2 | chr2:78901800-78903000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr2:78903000-78904000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
4 | chr2:78903400-78903800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:78903600-78904200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr2:78903800-78904200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr2:78904000-78904400 | Enhancers | HepG2 | liver |
8 | chr2:78904000-78904600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
9 | chr2:78904000-78904800 | Enhancers | Primary monocytes fromperipheralblood | blood |
10 | chr2:78904200-78904800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
11 | chr2:78904200-78905800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
12 | chr2:78904400-78904800 | Flanking Active TSS | HepG2 | liver |
13 | chr2:78904800-78905200 | Enhancers | HepG2 | liver |
14 | chr2:78909800-78910000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |